Last reviewed · How we verify
NCT03550560
EUS-Guided Drainage of Refractory Malignant Ascites
trial testing EUS-Guided drainage in Malignant Ascites in 100 participants. Status unknown.
1 September 2019
Quick facts
| Lead sponsor | Hospital Universitario Virgen Macarena |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 September 2018 |
| Primary completion | 1 September 2019 |
| Estimated completion | 1 September 2019 |
Drugs / interventions tested
- EUS-Guided drainage
Conditions studied
- Malignant Ascites — all drugs for Malignant Ascites →
Sponsor
Hospital Universitario Virgen Macarena
Who can join
18 and older, any sex, with Malignant Ascites. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the efficacy and safety of drainage of refractory malignant ascites by endoscopic ultrasound-guided (EUS-Guided) implantation of plastic prostheses. Patients with cancer older than 18 years with a life expectancy of less than 6 months who undergo EUS-Guided will be included in the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03550560
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malignant Ascites
Currently open trials in the same condition.
- NCT07397819 — Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor N · Phase 1, PHASE2 · recruiting
- NCT06432296 — Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody · Phase 3 · active not recruiting
- NCT06433869 — The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in th · Phase 2 · recruiting
- NCT04326946 — International Alfapump Cohort Study · active not recruiting
Other Hospital Universitario Virgen Macarena trials
Trials by the same sponsor.
- NCT06999317 — CARAMEL: Retrospective Study for Personalized Risk Assessment of Cardiovascular Disease in Menopausal and Perimenopausal · not yet recruiting
- NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
- NCT06664307 — Evaluation of the Efficacy and Safety of Portal Pressure Gradient (PPG) Measurement Guided by Endoscopic Ultrasound (EUS · not yet recruiting
- NCT05445752 — Conservative Nodal Surgery (Node-picking) of Patients With Stage III Melanoma With Low-burden of Nodal Disease (MELCONSU · unknown
- NCT06004258 — Reduction of Pain in Childhood Vaccination in the Primary Care Nurse Vaccination Consultation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03550560 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Virgen Macarena
- Last refreshed: 8 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03550560.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing